| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 5 |
| NetGPI | no | yes: 0, no: 5 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 5 |
| GO:0110165 | cellular anatomical entity | 1 | 5 |
Related structures:
AlphaFold database: E9AIU6
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 246 | 250 | PF00656 | 0.737 |
| CLV_C14_Caspase3-7 | 29 | 33 | PF00656 | 0.453 |
| CLV_NRD_NRD_1 | 127 | 129 | PF00675 | 0.493 |
| CLV_NRD_NRD_1 | 167 | 169 | PF00675 | 0.452 |
| CLV_PCSK_KEX2_1 | 127 | 129 | PF00082 | 0.493 |
| CLV_PCSK_KEX2_1 | 167 | 169 | PF00082 | 0.448 |
| CLV_PCSK_PC7_1 | 163 | 169 | PF00082 | 0.455 |
| CLV_PCSK_SKI1_1 | 5 | 9 | PF00082 | 0.584 |
| CLV_PCSK_SKI1_1 | 91 | 95 | PF00082 | 0.574 |
| DEG_SPOP_SBC_1 | 185 | 189 | PF00917 | 0.642 |
| DEG_SPOP_SBC_1 | 26 | 30 | PF00917 | 0.478 |
| DEG_SPOP_SBC_1 | 33 | 37 | PF00917 | 0.496 |
| DOC_CKS1_1 | 142 | 147 | PF01111 | 0.627 |
| DOC_USP7_MATH_1 | 18 | 22 | PF00917 | 0.447 |
| DOC_USP7_MATH_1 | 185 | 189 | PF00917 | 0.748 |
| DOC_USP7_MATH_1 | 47 | 51 | PF00917 | 0.599 |
| DOC_USP7_MATH_1 | 95 | 99 | PF00917 | 0.711 |
| DOC_WW_Pin1_4 | 141 | 146 | PF00397 | 0.700 |
| DOC_WW_Pin1_4 | 36 | 41 | PF00397 | 0.518 |
| LIG_14-3-3_CanoR_1 | 127 | 137 | PF00244 | 0.632 |
| LIG_14-3-3_CanoR_1 | 155 | 159 | PF00244 | 0.644 |
| LIG_14-3-3_CanoR_1 | 170 | 175 | PF00244 | 0.614 |
| LIG_APCC_ABBA_1 | 80 | 85 | PF00400 | 0.529 |
| LIG_BIR_III_2 | 175 | 179 | PF00653 | 0.689 |
| LIG_FHA_1 | 142 | 148 | PF00498 | 0.647 |
| LIG_FHA_1 | 151 | 157 | PF00498 | 0.645 |
| LIG_FHA_1 | 164 | 170 | PF00498 | 0.773 |
| LIG_FHA_2 | 129 | 135 | PF00498 | 0.679 |
| LIG_FHA_2 | 201 | 207 | PF00498 | 0.635 |
| LIG_FHA_2 | 27 | 33 | PF00498 | 0.478 |
| LIG_LIR_Apic_2 | 4 | 9 | PF02991 | 0.378 |
| LIG_LIR_Nem_3 | 219 | 224 | PF02991 | 0.713 |
| LIG_SH2_NCK_1 | 120 | 124 | PF00017 | 0.754 |
| LIG_SH2_PTP2 | 6 | 9 | PF00017 | 0.472 |
| LIG_SH2_STAP1 | 232 | 236 | PF00017 | 0.657 |
| LIG_SH2_STAT5 | 10 | 13 | PF00017 | 0.476 |
| LIG_SH2_STAT5 | 6 | 9 | PF00017 | 0.484 |
| LIG_SH2_STAT5 | 79 | 82 | PF00017 | 0.686 |
| LIG_SH3_3 | 177 | 183 | PF00018 | 0.706 |
| LIG_SUMO_SIM_par_1 | 182 | 190 | PF11976 | 0.638 |
| LIG_TRAF2_1 | 131 | 134 | PF00917 | 0.736 |
| LIG_TRAF2_1 | 203 | 206 | PF00917 | 0.641 |
| LIG_TRAF2_1 | 235 | 238 | PF00917 | 0.815 |
| LIG_WRC_WIRS_1 | 59 | 64 | PF05994 | 0.247 |
| MOD_CK1_1 | 13 | 19 | PF00069 | 0.402 |
| MOD_CK1_1 | 187 | 193 | PF00069 | 0.742 |
| MOD_CK1_1 | 260 | 266 | PF00069 | 0.641 |
| MOD_CK2_1 | 127 | 133 | PF00069 | 0.732 |
| MOD_CK2_1 | 18 | 24 | PF00069 | 0.507 |
| MOD_CK2_1 | 186 | 192 | PF00069 | 0.753 |
| MOD_CK2_1 | 200 | 206 | PF00069 | 0.639 |
| MOD_CK2_1 | 232 | 238 | PF00069 | 0.717 |
| MOD_CK2_1 | 32 | 38 | PF00069 | 0.449 |
| MOD_GlcNHglycan | 150 | 153 | PF01048 | 0.477 |
| MOD_GlcNHglycan | 16 | 19 | PF01048 | 0.625 |
| MOD_GlcNHglycan | 189 | 192 | PF01048 | 0.447 |
| MOD_GlcNHglycan | 227 | 230 | PF01048 | 0.612 |
| MOD_GlcNHglycan | 234 | 237 | PF01048 | 0.563 |
| MOD_GlcNHglycan | 97 | 100 | PF01048 | 0.493 |
| MOD_GSK3_1 | 10 | 17 | PF00069 | 0.486 |
| MOD_GSK3_1 | 150 | 157 | PF00069 | 0.760 |
| MOD_GSK3_1 | 159 | 166 | PF00069 | 0.662 |
| MOD_GSK3_1 | 24 | 31 | PF00069 | 0.473 |
| MOD_GSK3_1 | 257 | 264 | PF00069 | 0.646 |
| MOD_GSK3_1 | 32 | 39 | PF00069 | 0.464 |
| MOD_GSK3_1 | 95 | 102 | PF00069 | 0.686 |
| MOD_NEK2_1 | 1 | 6 | PF00069 | 0.383 |
| MOD_NEK2_1 | 11 | 16 | PF00069 | 0.375 |
| MOD_NEK2_1 | 184 | 189 | PF00069 | 0.672 |
| MOD_NEK2_1 | 230 | 235 | PF00069 | 0.765 |
| MOD_NEK2_1 | 25 | 30 | PF00069 | 0.447 |
| MOD_NEK2_1 | 94 | 99 | PF00069 | 0.623 |
| MOD_PIKK_1 | 101 | 107 | PF00454 | 0.637 |
| MOD_PKA_1 | 127 | 133 | PF00069 | 0.633 |
| MOD_PKA_2 | 127 | 133 | PF00069 | 0.633 |
| MOD_PKA_2 | 154 | 160 | PF00069 | 0.668 |
| MOD_PKB_1 | 161 | 169 | PF00069 | 0.688 |
| MOD_Plk_1 | 133 | 139 | PF00069 | 0.629 |
| MOD_ProDKin_1 | 141 | 147 | PF00069 | 0.701 |
| MOD_ProDKin_1 | 36 | 42 | PF00069 | 0.518 |
| TRG_ENDOCYTIC_2 | 77 | 80 | PF00928 | 0.699 |
| TRG_ER_diArg_1 | 160 | 163 | PF00400 | 0.765 |
| TRG_ER_diArg_1 | 167 | 170 | PF00400 | 0.711 |
| TRG_Pf-PMV_PEXEL_1 | 172 | 177 | PF00026 | 0.436 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A3Q8IFE3 | Leishmania donovani | 54% | 100% |
| A4I6W0 | Leishmania infantum | 55% | 100% |
| E9B1Y4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 51% | 100% |
| Q4Q676 | Leishmania major | 50% | 100% |